Never exclude any options. Push on all fronts. If they can...

Never exclude any options. Push on all fronts. If they can secure partnering, great. If they get a fantastic T/O offer, that's great too. Or secure partnering and then get a greater T/O offer; that's even greater. People who sold out for a few bucks will live to regret their decision. This company is a ready-made setup for any pharma player who wants to get into this space. The market of poor sufferers is vast and BOT is miles ahead.

I read once that Microsoft patents everything it does as they go along whether it's useful or not. To the point that they became the company filing the most patents in the world at the time. The idea, of course, is to kick down the ladders behind them as they proceed blocking anyone from following. It's not the nicest approach to business but it's effective and falls under the "moat" concept that Warren Buffet has famously talked about. BOT has a moat now that the product is shown to be efficacious.